Product Images Aricept

This text appears to be a table containing data on clinical improvement of patients taking different dosages of Aricept as compared to Placebo. The table lists the mean scores on the ADAS-cog measurement scale at baseline and after several weeks of drug treatment. It seems to be useful for clinicians and researchers studying the efficacy of Aricept in improving cognitive function.*

The text appears to be a table showing the change in ADAS-cog score and the cumulative percentage of patients in different treatment groups (Aricept 10mg/day, Aricept 5mg/day, and Placebo). The data suggests that patients in the Aricept 10mg/day group showed the most improvement in ADAS-cog score, with a cumulative percentage of 50% compared to placebo (9%) and Aricept 5mg/day (7%). The table also shows the change from baseline for each treatment group.*

This appears to be a chart or table related to a study of a medication called "icept" at a dosage of "10 mg/day," as well as another medication called "Arcept Smolday" and a placebo. The chart appears to track the percentage of patients who experienced varying degrees of improvement or decline on a "CIBIC-plus Rating." However, without more context it is difficult to provide a more specific description of the study or its findings.*

This text seems to be a table or a graph that shows clinical improvement after 31 months of drug treatment with Aricept 10 mg/day compared to placebo. However, due to the missing information and the presence of non-English characters, it is not possible to provide further details or context.*

The text represents a comparison between Aricept, a medication, and a placebo. A dosage of 10 mg per day of Aricept was administered and compared to an inactive placebo. The rest of the text seems to be a reference number or code. The chart measures an "ADCS-ADL Change from Baseline", which may indicate a comparison of cognitive function.*

The text appears to be a chart or graph displaying the cumulative percentage of patients for Aricept 23mg and Aricept 10mg. It also includes the SIB (Severe Impairment Battery) change from baseline for these patients.*

This data appears to be a table with medication dosages and patient improvement ratings, represented by percentages. The medications listed are Aricept at dosages of 23mg/day and 10mg/day. Improvement ratings are divided into five categories: Markedly improved, moderately improved, minimally improved, no change, and worse. The table also includes a CIBIC-plus rating, which is not explained in this excerpt.*